Viewing Study NCT00044135


Ignite Creation Date: 2025-12-24 @ 10:15 PM
Ignite Modification Date: 2026-05-30 @ 12:25 PM
Study NCT ID: NCT00044135
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2002-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Sponsor: Triangle Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None clevudine View
None hepatitis B View